Protein requirements for infant and follow-on formula manufactured from protein hydrolysates published
European Union
Mar 22, 2023
Commission Delegated Regulation (EU) 2023/589 of 10 January 2023 amending Delegated Regulation (EU) 2016/127 as regards the protein requirements for infant and follow-on formula manufactured from protein hydrolysate.
Upon request from the Commission, the Authority issued a scientific opinion on 9 March 2022 on the nutritional safety and suitability of that infant and follow-on formula (4). In that opinion, the Authority concluded that the protein hydrolysate in question is a nutritionally safe and suitable protein source for use in an infant and follow-on formula, as long as the formula in which it is used contains a minimum of 0,45 g/100 kJ (1,9 g/100 kcal) protein and complies with the other compositional criteria set out in Delegated Regulation (EU) 2016/127 and with the amino acid pattern contained in Section A of Annex III to that Regulation.
Article 1
Annexes I, II and III to Delegated Regulation (EU) 2016/127 are amended in accordance with the Annex to this Regulation.
For further information (in English), click on the Link
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
Amended maximum levels for the sum of 3-MCPD and 3-MCPD fatty acid esters in infant foods
European Union
Apr 08, 2024
FSSAI revises Standards for Children's Nutritional Foods
India
Mar 14, 2024
FSANZ revises the use of 2-fucosyl lactose produced by GM Corynebacterium glutamicum in infant formula
Australia
Feb 23, 2024
SFA proposes to extend use of additives in infant formula
Singapore
Feb 07, 2024
SAMR to require registration of liquid infant formula
China
Jan 24, 2024
Argentina - Compliance with the labeling of commercial milk formulas according to the International Code of Marketing of Breast-Milk Substitutes
Argentina
Jan 15, 2024
Application on the use of a GMO for production of 2′-Fucosyllactose (2′-FL) and use in infant formulas
Australia
Dec 26, 2023
Health Canada announces transition strategy to prepare for expiration of infant formula shortage policy
Canada
Dec 22, 2023
SFA removes melamine-related requirements for milk products imported from China
Singapore
Oct 27, 2023
2′-FL from a GMO strain of E. coli may be soon authorized in infant and toddler formulas
Canada
Oct 05, 2023
FDA updates infant formula compliance program
USA
Oct 04, 2023
Four human-identical milk oligosaccharides authorized to be used in infant formula
Australia
Sep 27, 2023
MHLW proposes to revise the approval requirements for infant formulas
Japan
Aug 21, 2023
First Global Congress to end harmful marketing of formula milk
Codex
Jun 26, 2023
